These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32962417)

  • 1. YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis.
    Arain F; Abraityte A; Bogdanova M; Solberg OG; Michelsen AE; Lekva T; Aakhus S; Holm S; Halvorsen B; Finsen AV; Vinge LE; Nymo S; Espeland T; Ranheim T; Aukrust P; Vaage IJ; Auensen A; Gullestad L; Ueland T
    Circ Heart Fail; 2020 Oct; 13(10):e006643. PubMed ID: 32962417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease.
    Schroder J; Jakobsen JC; Winkel P; Hilden J; Jensen GB; Sajadieh A; Larsson A; Ärnlöv J; Harutyunyan M; Johansen JS; Kjøller E; Gluud C; Kastrup J
    J Am Heart Assoc; 2020 Mar; 9(5):e014634. PubMed ID: 32114892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Circulating Inflammatory Proteins Associated with Calcific Aortic Valve Stenosis by Multiplex Analysis.
    Lin R; Zhu Y; Chen W; Wang Z; Wang Y; Du J
    Cardiovasc Toxicol; 2024 May; 24(5):499-512. PubMed ID: 38589550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    Hozumi H; Fujisawa T; Enomoto N; Nakashima R; Enomoto Y; Suzuki Y; Kono M; Karayama M; Furuhashi K; Murakami A; Inui N; Nakamura Y; Mimori T; Suda T
    J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valvular osteoclasts in calcification and aortic valve stenosis severity.
    Nagy E; Eriksson P; Yousry M; Caidahl K; Ingelsson E; Hansson GK; Franco-Cereceda A; Bäck M
    Int J Cardiol; 2013 Oct; 168(3):2264-71. PubMed ID: 23452891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study.
    Koos R; Brandenburg V; Mahnken AH; Schneider R; Dohmen G; Autschbach R; Marx N; Kramann R
    J Heart Valve Dis; 2013 May; 22(3):317-25. PubMed ID: 24151757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.
    Höbaus C; Tscharre M; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
    Atherosclerosis; 2018 Jul; 274():152-156. PubMed ID: 29783062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum chitotriosidase and YKL-40 in acute pancreatitis: Reliability as prognostic marker for disease severity and correlation with inflammatory markers.
    Ünal Çetin E; Kamiş F; Çetin AU; Beyazit Y; Kekilli M
    Turk J Med Sci; 2021 Dec; 51(6):3038-3046. PubMed ID: 34579512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measured and genetically predicted plasma YKL-40 levels and melanoma mortality.
    Ismail H; Helby J; Hölmich LR; Chakera AH; Bastholt L; Klyver H; Sjøgren P; Schmidt H; Schöllhammer L; Johansen JS; Nordestgaard BG; Bojesen SE
    Eur J Cancer; 2019 Nov; 121():74-84. PubMed ID: 31563729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
    Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Utility of Neutrophil-to-Lymphocyte Ratio on Adverse Clinical Outcomes in Patients with Severe Calcific Aortic Stenosis.
    Cho KI; Cho SH; Her AY; Singh GB; Shin ES
    PLoS One; 2016; 11(8):e0161530. PubMed ID: 27548384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.
    Spoorenberg SM; Vestjens SM; Rijkers GT; Meek B; van Moorsel CH; Grutters JC; Bos WJ;
    Respirology; 2017 Apr; 22(3):542-550. PubMed ID: 27782361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted Wnt modulators in symptomatic aortic stenosis.
    Askevold ET; Gullestad L; Aakhus S; Ranheim T; Tønnessen T; Solberg OG; Aukrust P; Ueland T
    J Am Heart Assoc; 2012 Dec; 1(6):e002261. PubMed ID: 23316316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children.
    Yang X; Sheng G
    BMC Pediatr; 2018 Dec; 18(1):381. PubMed ID: 30514252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis.
    Ramchand J; Patel SK; Kearney LG; Matalanis G; Farouque O; Srivastava PM; Burrell LM
    JACC Cardiovasc Imaging; 2020 Mar; 13(3):655-664. PubMed ID: 31607667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dephosphorylation of circulating human osteopontin correlates with severe valvular calcification in patients with calcific aortic valve disease.
    Sainger R; Grau JB; Poggio P; Branchetti E; Bavaria JE; Gorman JH; Gorman RC; Ferrari G
    Biomarkers; 2012 Mar; 17(2):111-8. PubMed ID: 22191734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
    Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
    Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
    Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
    Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol drinking modified the effect of plasma YKL-40 levels on stroke-specific mortality of acute ischemic stroke.
    Wang Z; Zhang K; Zhong C; Zhu Z; Zheng X; Yang P; Che B; Lu Y; Zhang Y; Xu T
    Neuroscience; 2024 Aug; 552():152-158. PubMed ID: 38944147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimarker Approach to Identify Patients With Higher Mortality and Rehospitalization Rate After Surgical Aortic Valve Replacement for Aortic Stenosis.
    Lindman BR; Clavel MA; Abu-Alhayja'a R; Côté N; Dagenais F; Novak E; Voisine P; Poulin A; Arsenault BJ; Desmeules P; Dahou A; Taster L; Aldahoun K; Bossé Y; Mathieu P; Pibarot P
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2172-2181. PubMed ID: 30409274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.